FEATURED COMPANIES
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Tecan Group Ltd.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Neuroscience Antibodies and Assays Market 2020-2024
The author has been monitoring the global neuroscience antibodies and assays market and it is poised to grow by USD 1.36 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The reports on global neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advances. In addition, advances in neuroscience instruments is anticipated to boost the growth of the global neuroscience antibodies and assays market as well.
Market Segmentation
The global neuroscience antibodies and assays market is segmented as below:
Product
This study identifies advances in neuroscience instruments as the prime reasons driving the global neuroscience antibodies and assays market growth during the next few years.
Prominent vendors in global neuroscience antibodies and assays market
We provide a detailed analysis of around 25 vendors operating in the global neuroscience antibodies and assays market, including some of the vendors such as Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The author has been monitoring the global neuroscience antibodies and assays market and it is poised to grow by USD 1.36 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The reports on global neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advances. In addition, advances in neuroscience instruments is anticipated to boost the growth of the global neuroscience antibodies and assays market as well.
Market Segmentation
The global neuroscience antibodies and assays market is segmented as below:
Product
- Consumables
- Instruments
- Asia
- Europe
- North America
- ROW
This study identifies advances in neuroscience instruments as the prime reasons driving the global neuroscience antibodies and assays market growth during the next few years.
Prominent vendors in global neuroscience antibodies and assays market
We provide a detailed analysis of around 25 vendors operating in the global neuroscience antibodies and assays market, including some of the vendors such as Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Tecan Group Ltd.
01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
08: GEOGRAPHIC LANDSCAPE
Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Consumables - Year-over-year growth 2020-2024 (%)
Exhibit 22: Instruments - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Instruments - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abcam Plc - Vendor overview
Exhibit 47: Abcam Plc - Business segments
Exhibit 48: Abcam Plc - Organizational developments
Exhibit 49: Abcam Plc - Geographic focus
Exhibit 50: Abcam Plc - Key offerings
Exhibit 51: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 52: Bio-Rad Laboratories Inc. - Business segments
Exhibit 53: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 54: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 55: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 56: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 57: Cell Signaling Technology Inc. - Vendor overview
Exhibit 58: Cell Signaling Technology Inc. - Business segments
Exhibit 59: Cell Signaling Technology Inc. - Organizational developments
Exhibit 60: Cell Signaling Technology Inc. - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 63: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 67: GenScript Biotech Corp. - Vendor overview
Exhibit 68: GenScript Biotech Corp. - Business segments
Exhibit 69: GenScript Biotech Corp. - Organizational developments
Exhibit 70: GenScript Biotech Corp. - Geographic focus
Exhibit 71: GenScript Biotech Corp. - Segment focus
Exhibit 72: GenScript Biotech Corp. - Key offerings
Exhibit 73: Merck KGaA - Vendor overview
Exhibit 74: Merck KGaA - Business segments
Exhibit 75: Merck KGaA - Organizational developments
Exhibit 76: Merck KGaA - Geographic focus
Exhibit 77: Merck KGaA - Segment focus
Exhibit 78: Merck KGaA - Key offerings
Exhibit 79: Rockland Immunochemicals Inc. - Vendor overview
Exhibit 80: Rockland Immunochemicals Inc. - Business segments
Exhibit 81: Rockland Immunochemicals Inc. - Organizational developments
Exhibit 82: Rockland Immunochemicals Inc. - Key offerings
Exhibit 83: Santa Cruz Biotechnology Inc. - Vendor overview
Exhibit 84: Santa Cruz Biotechnology Inc. - Business segments
Exhibit 85: Santa Cruz Biotechnology Inc. - Key offerings
Exhibit 86: Tecan Group Ltd. - Vendor overview
Exhibit 87: Tecan Group Ltd. - Business segments
Exhibit 88: Tecan Group Ltd. - Organizational developments
Exhibit 89: Tecan Group Ltd. - Geographic focus
Exhibit 90: Tecan Group Ltd. - Segment focus
Exhibit 91: Tecan Group Ltd. - Key offerings
Exhibit 92: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 93: Thermo Fisher Scientific Inc. - Business segments
Exhibit 94: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 95: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 96: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 97: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 98: Validation techniques employed for market sizing
Exhibit 99: Definition of market positioning of vendors
02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2019
- Market outlook
- Market size and forecast 2019-2024
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Consumables - Market size and forecast 2019-2024
- Instruments - Market size and forecast 2019-2024
- Market opportunity by product
08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
- Market drivers
- Market challenges
- High growth potential in emerging countries
- Increasing focus on neurological disease research
- Advances in neuroscience instruments
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abcam Plc
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Rockland Immunochemicals Inc.
- Santa Cruz Biotechnology Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Consumables - Year-over-year growth 2020-2024 (%)
Exhibit 22: Instruments - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Instruments - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abcam Plc - Vendor overview
Exhibit 47: Abcam Plc - Business segments
Exhibit 48: Abcam Plc - Organizational developments
Exhibit 49: Abcam Plc - Geographic focus
Exhibit 50: Abcam Plc - Key offerings
Exhibit 51: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 52: Bio-Rad Laboratories Inc. - Business segments
Exhibit 53: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 54: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 55: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 56: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 57: Cell Signaling Technology Inc. - Vendor overview
Exhibit 58: Cell Signaling Technology Inc. - Business segments
Exhibit 59: Cell Signaling Technology Inc. - Organizational developments
Exhibit 60: Cell Signaling Technology Inc. - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 63: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 67: GenScript Biotech Corp. - Vendor overview
Exhibit 68: GenScript Biotech Corp. - Business segments
Exhibit 69: GenScript Biotech Corp. - Organizational developments
Exhibit 70: GenScript Biotech Corp. - Geographic focus
Exhibit 71: GenScript Biotech Corp. - Segment focus
Exhibit 72: GenScript Biotech Corp. - Key offerings
Exhibit 73: Merck KGaA - Vendor overview
Exhibit 74: Merck KGaA - Business segments
Exhibit 75: Merck KGaA - Organizational developments
Exhibit 76: Merck KGaA - Geographic focus
Exhibit 77: Merck KGaA - Segment focus
Exhibit 78: Merck KGaA - Key offerings
Exhibit 79: Rockland Immunochemicals Inc. - Vendor overview
Exhibit 80: Rockland Immunochemicals Inc. - Business segments
Exhibit 81: Rockland Immunochemicals Inc. - Organizational developments
Exhibit 82: Rockland Immunochemicals Inc. - Key offerings
Exhibit 83: Santa Cruz Biotechnology Inc. - Vendor overview
Exhibit 84: Santa Cruz Biotechnology Inc. - Business segments
Exhibit 85: Santa Cruz Biotechnology Inc. - Key offerings
Exhibit 86: Tecan Group Ltd. - Vendor overview
Exhibit 87: Tecan Group Ltd. - Business segments
Exhibit 88: Tecan Group Ltd. - Organizational developments
Exhibit 89: Tecan Group Ltd. - Geographic focus
Exhibit 90: Tecan Group Ltd. - Segment focus
Exhibit 91: Tecan Group Ltd. - Key offerings
Exhibit 92: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 93: Thermo Fisher Scientific Inc. - Business segments
Exhibit 94: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 95: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 96: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 97: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 98: Validation techniques employed for market sizing
Exhibit 99: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Tecan Group Ltd.
The following companies as the key players in the global neuroscience antibodies and assays market: Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is advances in neuroscience instruments”
According to the report, one of the major drivers for this market is the technological advances.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is advances in neuroscience instruments”
According to the report, one of the major drivers for this market is the technological advances.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Abcam Plc
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Rockland Immunochemicals Inc.
- Santa Cruz Biotechnology Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.137
Note: Product cover images may vary from those shown
LOADING...
